Daniel C. Sadowski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Daniel C. Sadowski has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Martin P. Mintchev
University of Calgary, Engineering Complex
3 shared publications - Richard Neil Fedorak
Division of Gastroenterology, University of Alberta, Edmonton, AB, Canada
3 shared publications Adriana Lazarescu
Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
2 shared publicationsBradley Schwartz
Division of Urology, Southern Illinois University School of Medicine , Springfield, Illinois
2 shared publicationsConnie I. Prosser
Department of Laboratory Medicine and Pathology, Faculty of Medicine, University of Alberta, Edmonton, Canada
2 shared publications- Daniel C. Baumgart
Division of Gastroenterology and Hepatology, University of Alberta , Edmonton, Alberta
2 shared publications
Latest Publications
- Open Access
- 22 March 2024
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 12, e55314
The Effect of an Electronic Medical Record–Based Clinical Decision Support System on Adherence to Clinical Protocols in Inflammatory Bowel Disease Care: Interrupted Time Series Study
Background: Clinical decision support systems (CDSSs) embedded in electronic medical records (EMRs), also called electronic health records, have the potential to improve the adoption of clinical guidelines. The University of Alberta Inflammatory Bowel Disease (IBD) Group developed a CDSS for patients with IBD who might be experiencing disease flare and deployed it within a clinical information system in 2 continuous time periods. Objective: This study aims to evaluate the impact of the IBD CDSS on the adherence of health care providers (ie, physicians and nurses) to institutionally agreed clinical management protocols. Methods: A 2-period interrupted time series (ITS) design, comparing adherence to a clinical flare management protocol during outpatient visits before and after the CDSS implementation, was used. Each interruption was initiated with user training and a memo with instructions for use. A group of 7 physicians, 1 nurse practitioner, and 4 nurses were invited to use the CDSS. In total, 31,726 flare encounters were extracted from the clinical information system database, and 9217 of them were manually screened for inclusion. Each data point in the ITS analysis corresponded to 1 month of individual patient encounters, with a total of 18 months of data (9 before and 9 after interruption) for each period. The study was designed in accordance with the Statement on Reporting of Evaluation Studies in Health Informatics (STARE-HI) guidelines for health informatics evaluations. Results: Following manual screening, 623 flare encounters were confirmed and designated for ITS analysis. The CDSS was activated in 198 of 623 encounters, most commonly in cases where the primary visit reason was a suspected IBD flare. In Implementation Period 1, before-and-after analysis demonstrates an increase in documentation of clinical scores from 3.5% to 24.1% (P<.001), with a statistically significant level change in ITS analysis (P=.03). In Implementation Period 2, the before-and-after analysis showed further increases in the ordering of acute disease flare lab tests (47.6% to 65.8%; P<.001), including the biomarker fecal calprotectin (27.9% to 37.3%; P=.03) and stool culture testing (54.6% to 66.9%; P=.005); the latter is a test used to distinguish a flare from an infectious disease. There were no significant slope or level changes in ITS analyses in Implementation Period 2. The overall provider adoption rate was moderate at approximately 25%, with greater adoption by nurse providers (used in 30.5% of flare encounters) compared to physicians (used in 6.7% of flare encounters). Conclusions: This is one of the first studies to investigate the implementation of a CDSS for IBD, designed with a leading EMR software (Epic Systems), providing initial evidence of an improvement over routine care. Several areas for future research were identified, notably the effect of CDSSs on outcomes and how to design a CDSS with greater utility for physicians. CDSSs for IBD should also be evaluated on a larger scale; this can be facilitated by regional and national centralized EMR systems.
- 22 March 2024
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 12, e55314
Open AccessThe Effect of an Electronic Medical Record–Based Clinical Decision Support System on Adherence to Clinical Protocols in Inflammatory Bowel Disease Care: Interrupted Time Series Study
Background: Clinical decision support systems (CDSSs) embedded in electronic medical records (EMRs), also called electronic health records, have the potential to improve the adoption of clinical guidelines. The University of Alberta Inflammatory Bowel Disease (IBD) Group developed a CDSS for patients with IBD who might be experiencing disease flare and deployed it within a clinical information system in 2 continuous time periods. Objective: This study aims to evaluate the impact of the IBD CDSS on the adherence of health care providers (ie, physicians and nurses) to institutionally agreed clinical management protocols. Methods: A 2-period interrupted time series (ITS) design, comparing adherence to a clinical flare management protocol during outpatient visits before and after the CDSS implementation, was used. Each interruption was initiated with user training and a memo with instructions for use. A group of 7 physicians, 1 nurse practitioner, and 4 nurses were invited to use the CDSS. In total, 31,726 flare encounters were extracted from the clinical information system database, and 9217 of them were manually screened for inclusion. Each data point in the ITS analysis corresponded to 1 month of individual patient encounters, with a total of 18 months of data (9 before and 9 after interruption) for each period. The study was designed in accordance with the Statement on Reporting of Evaluation Studies in Health Informatics (STARE-HI) guidelines for health informatics evaluations. Results: Following manual screening, 623 flare encounters were confirmed and designated for ITS analysis. The CDSS was activated in 198 of 623 encounters, most commonly in cases where the primary visit reason was a suspected IBD flare. In Implementation Period 1, before-and-after analysis demonstrates an increase in documentation of clinical scores from 3.5% to 24.1% (P<.001), with a statistically significant level change in ITS analysis (P=.03). In Implementation Period 2, the before-and-after analysis showed further increases in the ordering of acute disease flare lab tests (47.6% to 65.8%; P<.001), including the biomarker fecal calprotectin (27.9% to 37.3%; P=.03) and stool culture testing (54.6% to 66.9%; P=.005); the latter is a test used to distinguish a flare from an infectious disease. There were no significant slope or level changes in ITS analyses in Implementation Period 2. The overall provider adoption rate was moderate at approximately 25%, with greater adoption by nurse providers (used in 30.5% of flare encounters) compared to physicians (used in 6.7% of flare encounters). Conclusions: This is one of the first studies to investigate the implementation of a CDSS for IBD, designed with a leading EMR software (Epic Systems), providing initial evidence of an improvement over routine care. Several areas for future research were identified, notably the effect of CDSSs on outcomes and how to design a CDSS with greater utility for physicians. CDSSs for IBD should also be evaluated on a larger scale; this can be facilitated by regional and national centralized EMR systems.
- Open Access
- 19 March 2024
- Published by Oxford University Press (OUP) in Journal of the Canadian Association of Gastroenterology
- Vol. 7 (4) , 319-328
Post-polypectomy surveillance: follow-up recommendations from the Alberta Colorectal Cancer Screening Program
In 2013, the Alberta Colorectal Cancer Screening Program (ACRCSP) initially published recommendations for post-colonoscopy follow-up and polypectomy. Over time, emerging evidence and evolving surveillance guidelines from various expert groups necessitated a comprehensive review to align with the healthcare landscape in Alberta. To accomplish this, an expert panel was convened. Using the Agree II tool, we identified high-quality Clinical Practice Guidelines that were relevant to the Alberta medical context. Recommendations from these guidelines were adapted to fit the specific needs of Alberta. Recognizing inconsistencies and gaps within the existing guidelines, we conducted targeted literature reviews to ensure a comprehensive and evidence-based approach to our recommendations. Our revised recommendations build upon the assumption that a high-quality index colonoscopy has been performed at baseline. They are intended to enhance the quality of care and reduce unnecessary procedures. As well, they align with the growing consensus in the scientific literature that individuals with low-risk tubular adenomas may not require aggressive colonoscopy surveillance. The updated Alberta recommendations aim to provide clear recommendations for practicing endoscopists, referring physicians, and their patients. They address crucial questions such as determining which patients should commence surveillance via colonoscopy and which individuals should return to average-risk screening using the fecal immunochemical test (FIT). Additionally, our recommendations outline the appropriate surveillance intervals for those requiring continued monitoring.
- 19 March 2024
- Published by Oxford University Press (OUP) in Journal of the Canadian Association of Gastroenterology
- Vol. 7 (4) , 319-328
Open AccessPost-polypectomy surveillance: follow-up recommendations from the Alberta Colorectal Cancer Screening Program
In 2013, the Alberta Colorectal Cancer Screening Program (ACRCSP) initially published recommendations for post-colonoscopy follow-up and polypectomy. Over time, emerging evidence and evolving surveillance guidelines from various expert groups necessitated a comprehensive review to align with the healthcare landscape in Alberta. To accomplish this, an expert panel was convened. Using the Agree II tool, we identified high-quality Clinical Practice Guidelines that were relevant to the Alberta medical context. Recommendations from these guidelines were adapted to fit the specific needs of Alberta. Recognizing inconsistencies and gaps within the existing guidelines, we conducted targeted literature reviews to ensure a comprehensive and evidence-based approach to our recommendations. Our revised recommendations build upon the assumption that a high-quality index colonoscopy has been performed at baseline. They are intended to enhance the quality of care and reduce unnecessary procedures. As well, they align with the growing consensus in the scientific literature that individuals with low-risk tubular adenomas may not require aggressive colonoscopy surveillance. The updated Alberta recommendations aim to provide clear recommendations for practicing endoscopists, referring physicians, and their patients. They address crucial questions such as determining which patients should commence surveillance via colonoscopy and which individuals should return to average-risk screening using the fecal immunochemical test (FIT). Additionally, our recommendations outline the appropriate surveillance intervals for those requiring continued monitoring.
- Open Access
- 23 February 2024
- Published by Oxford University Press (OUP) in Journal of the Canadian Association of Gastroenterology
- Vol. 7 (3) , 230-237
Gastroscopy for dyspeptic symptoms in patients <65 years has a low yield of clinically important findings: a retrospective study
Background: Dyspepsia is a common, generally low-risk gastrointestinal condition. The American College of Gastroenterology and Canadian Association of Gastroenterology recommend avoiding gastroscopy in healthy patients <60 years old. Many dyspeptic patients can be effectively managed in primary care. This study aimed to determine: (1) the proportion of gastroscopies performed for dyspepsia among patients <65 years old with no alarm symptoms or clinically appropriate indications and (2) to determine the frequency of clinically actionable findings and dyspepsia-related healthcare utilization in the year following gastroscopy. Methods: Outpatient endoscopy reports were sampled and reviewed retrospectively from 2019 to –2021 in Edmonton, Alberta to identify gastroscopies performed for the indication of dyspepsia. Gastroscopies were considered low-risk for significant endoscopic findings if age <65, no alarm symptoms or other concerning indications, and insufficient evidence that first-line treatments and diagnostic approaches had been tried prior to gastroscopy. Clinically important findings were defined as those impacting management, not otherwise identifiable non-invasively. Results: Of the 358 reviewed gastroscopies for dyspepsia, 293 (81.8%) had no alarm symptoms, and 130 (36.3%) had no alarm symptoms or other appropriate indications. Clinically important findings were identified in 9 (6.9%) of the 130 low-risk cases. In the year following, one patient (1/130) visited the emergency department 3 times for their symptoms and no patients required hospital admission. No malignancies were detected. Conclusions: Many gastroscopies are performed on patients <65 years old with dyspepsia, even when they lack alarm symptoms or other clinical indications, despite recommendations against this practice and low procedure yield. Strategies to improve the uptake of current guidelines may optimize endoscopy resource utilization.
- 23 February 2024
- Published by Oxford University Press (OUP) in Journal of the Canadian Association of Gastroenterology
- Vol. 7 (3) , 230-237
Open AccessGastroscopy for dyspeptic symptoms in patients <65 years has a low yield of clinically important findings: a retrospective study
Background: Dyspepsia is a common, generally low-risk gastrointestinal condition. The American College of Gastroenterology and Canadian Association of Gastroenterology recommend avoiding gastroscopy in healthy patients <60 years old. Many dyspeptic patients can be effectively managed in primary care. This study aimed to determine: (1) the proportion of gastroscopies performed for dyspepsia among patients <65 years old with no alarm symptoms or clinically appropriate indications and (2) to determine the frequency of clinically actionable findings and dyspepsia-related healthcare utilization in the year following gastroscopy. Methods: Outpatient endoscopy reports were sampled and reviewed retrospectively from 2019 to –2021 in Edmonton, Alberta to identify gastroscopies performed for the indication of dyspepsia. Gastroscopies were considered low-risk for significant endoscopic findings if age <65, no alarm symptoms or other concerning indications, and insufficient evidence that first-line treatments and diagnostic approaches had been tried prior to gastroscopy. Clinically important findings were defined as those impacting management, not otherwise identifiable non-invasively. Results: Of the 358 reviewed gastroscopies for dyspepsia, 293 (81.8%) had no alarm symptoms, and 130 (36.3%) had no alarm symptoms or other appropriate indications. Clinically important findings were identified in 9 (6.9%) of the 130 low-risk cases. In the year following, one patient (1/130) visited the emergency department 3 times for their symptoms and no patients required hospital admission. No malignancies were detected. Conclusions: Many gastroscopies are performed on patients <65 years old with dyspepsia, even when they lack alarm symptoms or other clinical indications, despite recommendations against this practice and low procedure yield. Strategies to improve the uptake of current guidelines may optimize endoscopy resource utilization.
- Open Access
- 13 December 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Effect of an Electronic Medical Record-Based Clinical Decision Support System on Adherence to Clinical Protocols: An Interrupted Time Series Study in Inflammatory Bowel Disease (Preprint)
BACKGROUND Electronic medical record (EMR) (also called electronic health record (EHR)) embedded clinical decision support systems (CDSS) have the potential to improve the adoption of clinical guidelines. The University of Alberta Inflammatory Bowel Disease (IBD) Group developed a CDSS for IBD patients with suspected disease flare and deployed it within a clinical information system (CIS) in two continuous time periods. OBJECTIVE This study aims to evaluate the impact of the IBD CDSS on health care provider (physicians and nurses) adherence to institutionally agreed clinical management protocols. METHODS Two-period interrupted time-series (ITS) design, comparing adherence to a clinical flare management protocol during outpatient visits pre- and post-implementation of the CDSS. Each interruption was initiated with user training and a memo with instructions for use. 7 physicians, 1 nurse practitioner, and 4 nurses were invited to use the CDSS. 31,726 flare encounters were extracted from the CIS database, after which 9,217 were manually screened for inclusion. Each data point in the ITS analysis corresponds to one month of individual patient encounters, with a total of 18 months of data, 9 pre- and 9 post-interruption, for each period. The study was designed in accordance with STARE-HI guidelines for health informatics evaluations. RESULTS Following manual screening, 623 flare encounters were confirmed and designated for ITS analysis. The CDSS was activated in 198/623 of the encounters, most commonly in cases where the primary visit reason was a suspected IBD flare. In Period 1, before-and-after analysis demonstrates an increase in documentation of clinical scores from 3.5% to 24.1% (P<.001), which also showed a statistically significant level change on ITS analysis (P=.028). In Period 2, before-and-after analysis showed further increases in ordering of acute disease flare lab tests (47.6% to 65.8%, P <.001), including the biomarker fecal calprotectin (27.9% to 37.3%, P=.028), and stool culture testing (54.6% to 66.9%, P=.005), the latter which is a test used to distinguish a flare from an infectious disease. There were no significant slope or level changes on ITS analyses in Period 2. The overall provider adoption rate was moderate at approximately 25%, with greater adoption by nurse providers (used in 30.5% of flare encounters) than physicians (used in 6.7% of flare encounters). CONCLUSIONS This is one of the first studies to investigate the implementation of a CDSS for IBD designed with a leading EMR software (Epic Systems, Verona, WI, USA), providing initial evidence of an improvement over routine care. Several areas for future research were identified, notably the effect of CDSS on outcomes, and how to design CDSS with greater utility for physicians. CDSS for IBD should also be evaluated on a larger scale, which can be facilitated by regional and national centralized EMR systems.
- 13 December 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEffect of an Electronic Medical Record-Based Clinical Decision Support System on Adherence to Clinical Protocols: An Interrupted Time Series Study in Inflammatory Bowel Disease (Preprint)
BACKGROUND Electronic medical record (EMR) (also called electronic health record (EHR)) embedded clinical decision support systems (CDSS) have the potential to improve the adoption of clinical guidelines. The University of Alberta Inflammatory Bowel Disease (IBD) Group developed a CDSS for IBD patients with suspected disease flare and deployed it within a clinical information system (CIS) in two continuous time periods. OBJECTIVE This study aims to evaluate the impact of the IBD CDSS on health care provider (physicians and nurses) adherence to institutionally agreed clinical management protocols. METHODS Two-period interrupted time-series (ITS) design, comparing adherence to a clinical flare management protocol during outpatient visits pre- and post-implementation of the CDSS. Each interruption was initiated with user training and a memo with instructions for use. 7 physicians, 1 nurse practitioner, and 4 nurses were invited to use the CDSS. 31,726 flare encounters were extracted from the CIS database, after which 9,217 were manually screened for inclusion. Each data point in the ITS analysis corresponds to one month of individual patient encounters, with a total of 18 months of data, 9 pre- and 9 post-interruption, for each period. The study was designed in accordance with STARE-HI guidelines for health informatics evaluations. RESULTS Following manual screening, 623 flare encounters were confirmed and designated for ITS analysis. The CDSS was activated in 198/623 of the encounters, most commonly in cases where the primary visit reason was a suspected IBD flare. In Period 1, before-and-after analysis demonstrates an increase in documentation of clinical scores from 3.5% to 24.1% (P<.001), which also showed a statistically significant level change on ITS analysis (P=.028). In Period 2, before-and-after analysis showed further increases in ordering of acute disease flare lab tests (47.6% to 65.8%, P <.001), including the biomarker fecal calprotectin (27.9% to 37.3%, P=.028), and stool culture testing (54.6% to 66.9%, P=.005), the latter which is a test used to distinguish a flare from an infectious disease. There were no significant slope or level changes on ITS analyses in Period 2. The overall provider adoption rate was moderate at approximately 25%, with greater adoption by nurse providers (used in 30.5% of flare encounters) than physicians (used in 6.7% of flare encounters). CONCLUSIONS This is one of the first studies to investigate the implementation of a CDSS for IBD designed with a leading EMR software (Epic Systems, Verona, WI, USA), providing initial evidence of an improvement over routine care. Several areas for future research were identified, notably the effect of CDSS on outcomes, and how to design CDSS with greater utility for physicians. CDSS for IBD should also be evaluated on a larger scale, which can be facilitated by regional and national centralized EMR systems.
- Open Access
- 28 August 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (17) , 9098
Delayed Colorectal Cancer Diagnosis during the COVID-19 Pandemic in Alberta: A Framework for Analyzing Barriers to Diagnosis and Generating Evidence to Support Health System Changes Aimed at Reducing Time to Diagnosis
The frequency of colorectal cancer (CRC) diagnosis has decreased due to the COVID-19 pandemic. Health system planning is needed to address the backlog of undiagnosed patients. We developed a framework for analyzing barriers to diagnosis and estimating patient volumes under different system relaunch scenarios. This retrospective study included CRC cases from the Alberta Cancer Registry for the pre-pandemic (1 January 2016–4 March 2020) and intra-pandemic (5 March 2020–1 July 2020) periods. The data on all the diagnostic milestones in the year prior to a CRC diagnosis were obtained from administrative health data. The CRC diagnostic pathways were identified, and diagnostic intervals were measured. CRC diagnoses made during hospitalization were used as a proxy for severe disease at presentation. A modified Poisson regression analysis was used to estimate the adjusted relative risk (adjRR) and a 95% confidence interval (CI) for the effect of the pandemic on the risk of hospital-based diagnoses. During the study period, 8254 Albertans were diagnosed with CRC. During the pandemic, diagnosis through asymptomatic screening decreased by 6·5%. The adjRR for hospital-based diagnoses intra-COVID-19 vs. pre-COVID-19 was 1.24 (95% CI: 1.03, 1.49). Colonoscopies were identified as the main bottleneck for CRC diagnoses. To clear the backlog before progression is expected, high-risk subgroups should be targeted to double the colonoscopy yield for CRC diagnosis, along with the need for a 140% increase in monthly colonoscopy volumes for a period of 3 months. Given the substantial health system changes required, it is unlikely that a surge in CRC cases will be diagnosed over the coming months. Administrators in Alberta are using these findings to reduce wait times for CRC diagnoses and monitor progression.
- 28 August 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (17) , 9098
Open AccessDelayed Colorectal Cancer Diagnosis during the COVID-19 Pandemic in Alberta: A Framework for Analyzing Barriers to Diagnosis and Generating Evidence to Support Health System Changes Aimed at Reducing Time to Diagnosis
The frequency of colorectal cancer (CRC) diagnosis has decreased due to the COVID-19 pandemic. Health system planning is needed to address the backlog of undiagnosed patients. We developed a framework for analyzing barriers to diagnosis and estimating patient volumes under different system relaunch scenarios. This retrospective study included CRC cases from the Alberta Cancer Registry for the pre-pandemic (1 January 2016–4 March 2020) and intra-pandemic (5 March 2020–1 July 2020) periods. The data on all the diagnostic milestones in the year prior to a CRC diagnosis were obtained from administrative health data. The CRC diagnostic pathways were identified, and diagnostic intervals were measured. CRC diagnoses made during hospitalization were used as a proxy for severe disease at presentation. A modified Poisson regression analysis was used to estimate the adjusted relative risk (adjRR) and a 95% confidence interval (CI) for the effect of the pandemic on the risk of hospital-based diagnoses. During the study period, 8254 Albertans were diagnosed with CRC. During the pandemic, diagnosis through asymptomatic screening decreased by 6·5%. The adjRR for hospital-based diagnoses intra-COVID-19 vs. pre-COVID-19 was 1.24 (95% CI: 1.03, 1.49). Colonoscopies were identified as the main bottleneck for CRC diagnoses. To clear the backlog before progression is expected, high-risk subgroups should be targeted to double the colonoscopy yield for CRC diagnosis, along with the need for a 140% increase in monthly colonoscopy volumes for a period of 3 months. Given the substantial health system changes required, it is unlikely that a surge in CRC cases will be diagnosed over the coming months. Administrators in Alberta are using these findings to reduce wait times for CRC diagnoses and monitor progression.
- 1 February 2021
- Published by Elsevier in Surface and Coatings Technology
- Vol. 407, 126762
Tunable SiO2 to SiOxCyH films by ozone assisted chemical vapor deposition from tetraethylorthosilicate and hexamethyldisilazane mixtures
- 1 February 2021
- Published by Elsevier in Surface and Coatings Technology
- Vol. 407, 126762
Tunable SiO2 to SiOxCyH films by ozone assisted chemical vapor deposition from tetraethylorthosilicate and hexamethyldisilazane mixtures
- Open Access
- 5 June 2019
- Published by Oxford University Press (OUP) in Journal of the Canadian Association of Gastroenterology
- Vol. 3 (6) , e28-e31
Meeting the Motility Educational Requirements of the Gastroenterology Trainee in the 21st Century
Gastrointestinal (GI) motility and functional disorders comprise over two-third of referrals to GI specialists yet training programs are disproportionately focused on endoscopy, inflammatory bowel disease and liver disease. Trainees at many centres receive minimal or no formal training in motility disorders and have little or no exposure to motility testing. Our purpose was to develop an educational intervention to address this learning need. We designed a formal training program comprised of didactic sessions, workshops and hands-on motility sessions with live demonstrations designed to be held over the course of a weekend. Faculty for the course were experienced GI motility experts from across Canada. Resident trainees from all Canadian GI fellowship programs were invited to attend. Pre- and post-tests were administered to measure the baseline learning needs and the impact of the program. Course evaluations were completed by attendees. Three annual courses were offered over the past 3 years. Both adult and paediatric gastroenterology trainees attended the programs. The majority of training programs from Canada were represented. Baseline testing of attendees revealed a fundamental lack of understanding of GI motility concepts and their clinical implications. Postcourse test scores demonstrated a significant improvement in motility knowledge. Course evaluations of the content and faculty presentations received uniformly positive reviews. There is a pervasive lack of clinical knowledge of GI motility among Canadian GI subspecialty trainees. A focused weekend intensive course is one step in addressing this learning need.
- 5 June 2019
- Published by Oxford University Press (OUP) in Journal of the Canadian Association of Gastroenterology
- Vol. 3 (6) , e28-e31
Open AccessMeeting the Motility Educational Requirements of the Gastroenterology Trainee in the 21st Century
Gastrointestinal (GI) motility and functional disorders comprise over two-third of referrals to GI specialists yet training programs are disproportionately focused on endoscopy, inflammatory bowel disease and liver disease. Trainees at many centres receive minimal or no formal training in motility disorders and have little or no exposure to motility testing. Our purpose was to develop an educational intervention to address this learning need. We designed a formal training program comprised of didactic sessions, workshops and hands-on motility sessions with live demonstrations designed to be held over the course of a weekend. Faculty for the course were experienced GI motility experts from across Canada. Resident trainees from all Canadian GI fellowship programs were invited to attend. Pre- and post-tests were administered to measure the baseline learning needs and the impact of the program. Course evaluations were completed by attendees. Three annual courses were offered over the past 3 years. Both adult and paediatric gastroenterology trainees attended the programs. The majority of training programs from Canada were represented. Baseline testing of attendees revealed a fundamental lack of understanding of GI motility concepts and their clinical implications. Postcourse test scores demonstrated a significant improvement in motility knowledge. Course evaluations of the content and faculty presentations received uniformly positive reviews. There is a pervasive lack of clinical knowledge of GI motility among Canadian GI subspecialty trainees. A focused weekend intensive course is one step in addressing this learning need.
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S275-S276
Sa1304 Catheter-Based Acoustic Interrogation Device for Real-Time Monitoring of the Dynamics of the Lower Esophageal Sphincter: A Pilot Canine Study
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S275-S276
Sa1304 Catheter-Based Acoustic Interrogation Device for Real-Time Monitoring of the Dynamics of the Lower Esophageal Sphincter: A Pilot Canine Study
- Open Access
- 1 February 2016
- Published by SAGE Publications in Journal of Endourology Case Reports
- Vol. 2 (1) , 96-98
Primary Renal Lymphoma Identified in a Robot-Assisted Laparoscopic Nephroureterectomy Specimen
Background: Although renal involvement is often present in non-Hodgkin's lymphoma (NHL), primary renal NHL is a rare diagnosis. Case Presentation: We present a case report of a 72-year-old asymptomatic male who underwent a robot-assisted laparoscopic radical nephroureterectomy on an atrophic left kidney with evidence of an infiltrating mass. Pathology report demonstrated a grade 1 follicular lymphoma. Conclusion: Lymphoma is a differential that should be considered when evaluating a renal mass. Chemotherapy and radiation are the mainstays of treatment.
- 1 February 2016
- Published by SAGE Publications in Journal of Endourology Case Reports
- Vol. 2 (1) , 96-98
Open AccessPrimary Renal Lymphoma Identified in a Robot-Assisted Laparoscopic Nephroureterectomy Specimen
Background: Although renal involvement is often present in non-Hodgkin's lymphoma (NHL), primary renal NHL is a rare diagnosis. Case Presentation: We present a case report of a 72-year-old asymptomatic male who underwent a robot-assisted laparoscopic radical nephroureterectomy on an atrophic left kidney with evidence of an infiltrating mass. Pathology report demonstrated a grade 1 follicular lymphoma. Conclusion: Lymphoma is a differential that should be considered when evaluating a renal mass. Chemotherapy and radiation are the mainstays of treatment.
- Open Access
- 1 November 2015
- Published by SAGE Publications in Journal of Endourology Case Reports
- Vol. 1 (1) , 78-80
Two Unexpected Tumors in a Laparoscopic Nephrectomy Specimen, Including a Rare Tubulocystic Renal-Cell Carcinoma: A Case Report
We present a case of a 52-year-old Caucasian male who underwent a laparoscopic nephrectomy for an atrophic kidney and was found to have two unexpected, synchronous kidney cancers. He had a remote history of testicular cancer complicated by lymphadenopathy and external ureteral compression. Over time, he developed an atrophic left kidney from obstructive uropathy. Years later, due to flank pain and renal scintigraphy showing minimal function, a laparoscopic nephrectomy was performed. Final pathology demonstrated papillary renal-cell carcinoma (RCC) and tubulocystic RCC. Tubulocystic RCC is a rare neoplasm thought to be an indolent subset of collecting duct carcinoma, but was identified as a unique entity in 2004. Currently, there are ∼100 cases of this neoplasm in the literature.
- 1 November 2015
- Published by SAGE Publications in Journal of Endourology Case Reports
- Vol. 1 (1) , 78-80
Open AccessTwo Unexpected Tumors in a Laparoscopic Nephrectomy Specimen, Including a Rare Tubulocystic Renal-Cell Carcinoma: A Case Report
We present a case of a 52-year-old Caucasian male who underwent a laparoscopic nephrectomy for an atrophic kidney and was found to have two unexpected, synchronous kidney cancers. He had a remote history of testicular cancer complicated by lymphadenopathy and external ureteral compression. Over time, he developed an atrophic left kidney from obstructive uropathy. Years later, due to flank pain and renal scintigraphy showing minimal function, a laparoscopic nephrectomy was performed. Final pathology demonstrated papillary renal-cell carcinoma (RCC) and tubulocystic RCC. Tubulocystic RCC is a rare neoplasm thought to be an indolent subset of collecting duct carcinoma, but was identified as a unique entity in 2004. Currently, there are ∼100 cases of this neoplasm in the literature.